Clinical Trial Update: Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update for HLCM051 (MultiStem) assessing efficacy and safety in adult pneumonic acute respiratory distress syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome Adult

Drugs mentioned

• HLCM051 (MultiStem) (HLCM051)

Snippet

Sponsor: Healios K.K. | Conditions: Respiratory Distress Syndrome, Adult | Phase 2 | Status: COMPLETED